Thus, cancer cells can exploit both of the anti-apoptotic actions of Bcl-2 to promote their survival, dependent on the challenging conditions operative in these cells, either by Bim upregulation or by IP3R2 upregulation. The gene discussed is ITPR2; the disease is cancer.